Issue

Vol. 34 No. 9 (2022): Vol 34 Issue 9

Copyright (c) 2022 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Pulmonary Phospholipid Components as Promising Natural Inhibitors against COVID-19 Mpro; Molecular Docking Analysis Based Study

https://doi.org/10.14233/ajchem.2022.23691
Mohammed A. Hussein
Department of Biotechnology, Faculty of Applied Health Sciences Technology, October 6 University, Sixth of October City, Egypt
Heba M. Abo-Salem
Department of Chemistry and Natural Compounds, Pharmaceutical and Drug industries Research Division, National Research Center, Dokki, Giza, Egypt
Ahmed M. Moro
Department of Biophysics, Faculty of Applied Medical Sciences, October 6 University, Sixth of October City, Egypt
Ebtsam A. Abdel-Wahab
Department of Biophysics, Faculty of Applied Medical Sciences, October 6 University, Sixth of October City, Egypt
Ali A Ali
Department of Food Science, Faculty of Agriculture, Ain Shams University, Cairo, Egypt
Shaimaa A. Abdelkawy
Department of Biotechnology, Faculty of Applied Health Sciences Technology, October 6 University, Sixth of October City, Egypt

Corresponding Author(s) : Mohammed A. Hussein

prof.husseinma@o6u.edu.eg

Asian Journal of Chemistry, Vol. 34 No. 9 (2022): Vol 34 Issue 9

Abstract

The ongoing pandemic of COVID-19 caused by the severe acute respiratory syndrome SARS-CoV-2 has become a global crisis. Phospholipids are structural components of mammalian cell membranes that suppress viral attachment to the plasma membrane and subsequent replication in lung cells. Using the molecular docking approach, the inhibitory activity of phosphatidylcholine, dipalmitoylphosphatidylcholine, phosphatidylethanolamine, phosphatidylglycerol, phosphatidylinositol, lysobisphosphatidic acid and sphingomyelin against SARS CoV-2 by targeting main protease (Mpro, PDB code: 6LU7) has been investigated. All phospholipids established excellent binding to Mpro active bocket by forming several H-bonds with the catalytic amino acids Cys145 and His4, as well as various amino acids involved in the bocket. Furthermore, a potent binding affinity is increased from -7.01 to -9.16 kcal/mol compared to compound N3 (N-[(5-methylisoxazol-3-yl)carbonyl]alanyl-L (where L = valyl-N-1-(1R,2Z)-4-(benzyloxy)-4-oxo-1-{[(3R)-2-oxopyrrolidin-3-yl]methyl}but-2-enyl)-L-leucinamide), a peptide linker, inhibitor for Covid-19 main protease. Co-crystalline ligand of enzyme 6LU7 of -9.99 kcal/mol. The sphingomyelin has the same binding affinity to main protease when compared to compound N3. These findings implied that the selected compounds have the potential to be developed as novel SARS-CoV-2 inhibitors. Therefore, improved, well-designed, potent and structurally and pharmacokinetically effective drugs are urgently needed. Further investigations should focus on validating and finalizing effective drugs for COVID-19 beyond preliminary in silico and in vivo screening.

Keywords

Dipalmitoylphosphatidyl choline Phosphatidyl glycerol Lysobisphosphatidic acid Sphingomyelin SARS CoV-2 Protease
A. Hussein, M., M. Abo-Salem, H., M. Moro, A., A. Abdel-Wahab, E., A Ali, A., & A. Abdelkawy, S. (2022). Pulmonary Phospholipid Components as Promising Natural Inhibitors against COVID-19 Mpro; Molecular Docking Analysis Based Study. Asian Journal of Chemistry, 34(9), 2191–2197. https://doi.org/10.14233/ajchem.2022.23691
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. H. Lu, C.W. Stratton and Y.W. Tang, J. Med. Virol., 92, 401 (2020); https://doi.org/10.1002/jmv.25678
  2. G. Lippi and M. Plebani, Clin. Chim. Acta, 505, 190 (2020); https://doi.org/10.1016/j.cca.2020.03.004
  3. P. Mehta, D.F. McAuley, M. Brown, E. Sanchez, R.S. Tattersall and J.J. Manson, Lancet, 395, 1033 (2020); https://doi.org/10.1016/S0140-6736(20)30628-0
  4. J. Stebbing, A. Phelan, I. Griffin, C. Tucker, O. Oechsle, D. Smith and P. Richardson, Lancet Infect. Dis., 20, 400 (2020); https://doi.org/10.1016/S1473-3099(20)30132-8
  5. M.Z. Tay, C.M. Poh, L. Renia, P.A. MacAry and L.F.P. Ng, Nat. Rev. Immunol., 20, 363 (2020); https://doi.org/10.1038/s41577-020-0311-8
  6. S. Akpinar, M. Oran, M. Dogan, A. Çelikkol, I. Erdem and B. Turgut, Eur. Rev. Med. Pharmacol. Sci., 25, 5304 (2021); https://doi.org/10.26355/eurrev_202108_26551
  7. O.V. Oskolkova, V. Godschachner and V.N. Bochkov, Inflammation, 40, 530 (2017); https://doi.org/10.1007/s10753-016-0499-8
  8. S. Karnati, V. Garikapati, G. Liebisch, P.P. Van Veldhoven, B. Spengler, G. Schmitz and E. Baumgart-Vogt, PLoS One, 13, e0203464 (2018); https://doi.org/10.1371/journal.pone.0203464
  9. S.N. Nguyen, J.E. Kyle, S.E. Dautel, R. Sontag, T. Luders, R. Corley, C. Ansong, J. Carson and J. Laskin, Anal. Chem., 91, 11629 (2019); https://doi.org/10.1021/acs.analchem.9b02045
  10. W. Bernhard, Ann. Anat., 208, 146 (2016); https://doi.org/10.1016/j.aanat.2016.08.003
  11. S.A. Boshra and M.A. Hussein, Int. J. Phytomed., 8, 217 (2016).
  12. W. Stremmel, R. Ehehalt, S. Staffer, S. Stoffels, A. Mohr, M. Karner and A. Braun, Dig. Dis., 30(Suppl. 3), 85 (2012); https://doi.org/10.1159/000342729
  13. T. Becker, G. Loch, M. Beyer, I. Zinke, A.C. Aschenbrenner, P. Carrera, T. Inhester, J. Schultze and M. Hoch, Nature, 463, 369 (2010); https://doi.org/10.1038/nature08698
  14. W. Stremmel, Z. Gastroenterol., 51, 384 (2013); https://doi.org/10.1055/s-0033-1335042
  15. W. Stremmel, A. Hanemann, A. Braun, S. Stoffels, M. Karner, S. Fazeli and R. Ehehalt, Expert Opin. Investig. Drugs, 19, 1623 (2010); https://doi.org/10.1517/13543784.2010.535514
  16. I. Bersani, C.P. Speer and S. Kunzmann, Expert Rev. Anti Infect. Ther., 10, 573 (2012); https://doi.org/10.1586/eri.12.34
  17. S.R. Bates, Cell. Physiol. Biochem., 25, 41 (2010); https://doi.org/10.1159/000272062
  18. M.X. Rojas-Reyes, C.J. Morley and R. Soll, Cochrane Database Syst. Rev., 3, CD000510 (2012); https://doi.org/10.1002/14651858.CD000510.pub2
  19. M.S. Dunn, J. Kaempf, A. de Klerk, R. de Klerk, M. Reilly, D. Howard, K. Ferrelli, J. O’Conor and R.F. Soll, Pediatrics, 128, e1069 (2011); https://doi.org/10.1542/peds.2010-3848
  20. N. Seger and R. Soll, Cochrane Database Syst. Rev., 2, CD007836 (2009); https://doi.org/10.1002/14651858.CD007836
  21. A. Hamvas, Chin. Med. J. (Engl.), 123, 2943 (2010).
  22. T.H. Garmany, J.A. Wambach, H.B. Heins, J.M. Watkins-Torry, D.J. Wegner, K. Bennet, P. An, G. Land, O.D. Saugstad, H. Henderson, L.M. Nogee, F.S. Cole and A. Hamvas, Pediatr. Res., 63, 645 (2008); https://doi.org/10.1203/PDR.0b013e31816fdbeb
  23. V. Boggaram, Clin. Sci., 116, 27 (2009); https://doi.org/10.1042/CS20080068
  24. R.M. DiBlasi and I.M. Cheifetz, Respir. Care, 56, 1466 (2011); https://doi.org/10.4187/respcare.01505
  25. J.E. Vance, Biochim. Biophys. Acta, 1841, 595 (2014); https://doi.org/10.1016/j.bbalip.2013.11.014
  26. J.E. Vance, Traffic, 16, 1 (2015); https://doi.org/10.1111/tra.12230
  27. K.S. Dimmer and D. Rapaport, Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1862, 69 (2017); https://doi.org/10.1016/j.bbalip.2016.07.010
  28. T. Tatsuta and T. Langer, Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1862, 81 (2017); https://doi.org/10.1016/j.bbalip.2016.08.006
  29. M.G. Acoba, N. Senoo and S.M. Claypool, J. Cell Biol., 219, e202003131 (2020); https://doi.org/10.1083/jcb.202003131
  30. J.Y. Choi, M.T. Duraisingh, M. Marti, C. Ben Mamoun and D.R. Voelker, J. Biol. Chem., 290, 10972 (2015); https://doi.org/10.1074/jbc.M115.642413
  31. J.-Y. Choi, Y. Augagneur, C.B. Mamoun and D.R. Voelker, J. Biol. Chem., 287, 222 (2012); https://doi.org/10.1074/jbc.M111.313676
  32. N.R. Deleault, J.R. Piro, D.J. Walsh, F. Wang, J. Ma, J.C. Geoghegan and S. Supattapone, Proc. Natl. Acad. Sci. USA, 109, 8546 (2012); https://doi.org/10.1073/pnas.1204498109
  33. G. D’Angelo, S. Moorthi and C. Luberto, Adv. Cancer Res., 140, 61 (2018); https://doi.org/10.1016/bs.acr.2018.04.009
  34. Z. Li, T.K. Hailemariam, H. Zhou, Y. Li, D.C. Duckworth, D.A. Peake, Y. Zhang, M.S. Kuo, G. Cao and X.C. Jiang, Biochim. Biophys. Acta, 1771, 1186 (2007); https://doi.org/10.1016/j.bbalip.2007.05.007
  35. T. Ding, Z. Li, T. Hailemariam, S. Mukherjee, F.R. Maxfield, M.-P. Wu and X.-C. Jiang, J. Lipid Res., 49, 376 (2008); https://doi.org/10.1194/jlr.M700401-JLR200
  36. L. Hua, N. Wu, R. Zhao, X. He, Q. Liu, X. Li, Z. He, L. Yu and N. Yan, Int. J. Mol. Sci., 20, 2861 (2019); https://doi.org/10.3390/ijms20122861
  37. X. Li, T. Luo, H. Li and N. Yan, Molecules, 25, 4231 (2020); https://doi.org/10.3390/molecules25184231
  38. Y. Chen and Y. Cao, Biol. Chem., 398, 1319 (2017); https://doi.org/10.1515/hsz-2017-0148
  39. H.A. El-Gizawy and M.A. Hussein, Int. J. Phytomed., 7, 219 (2015).
  40. N.A.E.K. Gobba, A.A. Hussein, D.E. El Sharawy and M.A. Hussein, Arch. Environ. Occup. Health, 73, 189 (2018); https://doi.org/10.1080/19338244.2017.1314930
  41. M. Leppkes, J. Knopf, E. Naschberger, A. Lindemann, J. Singh, I. Herrmann, M. Stürzl, L. Staats, A. Mahajan, C. Schauer, A.N. Kremer, S. Völkl, K. Amann, K. Evert, C. Falkeis, A. Wehrfritz, R.J. Rieker, A. Hartmann, A.E. Kremer, M.F. Neurath, L.E. Muñoz, G. Schett and M. Herrmann, EBioMedicine, 58, 102925 (2020); https://doi.org/10.1016/j.ebiom.2020.102925
  42. B. Gallo Marin, G. Aghagoli, K. Lavine, L. Yang, E.J. Siff, S.S. Chiang, T.P. Salazar-Mather, L. Dumenco, M.C. Savaria, S.N. Aung, T. Flanigan and I.C. Michelow, Rev. Med. Virol., 31, 1 (2021); https://doi.org/10.1002/rmv.2146
  43. M.A. Hussein, Coronaviruses, 2, Article ID: e080921192222 (2021); https://doi.org/10.2174/2666796702666210311123323
  44. M.A. Hussein, N.E.M. Ismail, A.H. Mohamed, R.M. Borik, A.A. Ali and Y.O. Mosaad, Bioinform. Biol. Insights, 15, 11779322211055891 (2021); https://doi.org/10.1177/11779322211055891
  45. Z. Jin, X. Du, Y. Xu, Y. Deng, M. Liu, Y. Zhao, B. Zhang, X. Li, L. Zhang, C. Peng, Y. Duan, J. Yu, L. Wang, K. Yang, F. Liu, R. Jiang, X. Yang, T. You, X. Liu, X. Yang, F. Bai, H. Liu, X. Liu, L.W. Guddat, W. Xu, G. Xiao, C. Qin, Z. Shi, H. Jiang, Z. Rao and H. Yang, Nature, 582, 289 (2020); https://doi.org/10.1038/s41586-020-2223-y
  46. S. Ullrich and C. Nitsche, Bioorg. Med. Chem. Lett., 30, 127377 (2020); https://doi.org/10.1016/j.bmcl.2020.127377
  47. P. Eleftheriou, D. Amanatidou, A. Petrou and A. Geronikaki, Molecules, 25, 2529 (2020); https://doi.org/10.3390/molecules25112529
  48. K. Akaji and H. Konno, Molecules, 25, 3920 (2020); https://doi.org/10.3390/molecules25173920
  49. T. Mohammad, A. Shamsi, S. Anwar, M. Umair, A. Hussain, M.T. Rehman, M.F. AlAjmi, A. Islam and M.I. Hassan, Virus Res., 288, 198102 (2020); https://doi.org/10.1016/j.virusres.2020.198102
  50. B. Goyal and D. Goyal, ACS Comb. Sci., 22, 297 (2020); https://doi.org/10.1021/acscombsci.0c00058
  51. M.L. Holshue, C. DeBolt, S. Lindquist, K.H. Lofy, J. Wiesman, H. Bruce, C. Spitters, K. Ericson, S. Wilkerson, A. Tural, G. Diaz, A. Cohn, L. Fox, A. Patel, S.I. Gerber, L. Kim, S. Tong, X. Lu, S. Lindstrom, M.A. Pallansch, W.C. Weldon, H.M. Biggs, T.M. Uyeki and S.K. Pillai, N. Engl. J. Med., 382, 929 (2020); https://doi.org/10.1056/NEJMoa2001191
  52. Y. Wang, D. Zhang, G. Du, R. Du, J. Zhao, Y. Jin, S. Fu, L. Gao, Z. Cheng, Q. Lu, Y. Hu, G. Luo, K. Wang, Y. Lu, H. Li, S. Wang, S. Ruan, C. Yang, C. Mei, Y. Wang, D. Ding, F. Wu, X. Tang, X. Ye, Y. Ye, B. Liu, J. Yang, W. Yin, A. Wang, G. Fan, F. Zhou, Z. Liu, X. Gu, J. Xu, L. Shang, Y. Zhang, L. Cao, T. Guo, Y. Wan, H. Qin, Y. Jiang, T. Jaki, F.G. Hayden, P.W. Horby, B. Cao and C. Wang, Lancet, 395, 1569 (2020); https://doi.org/10.1016/S0140-6736(20)31022-9
  53. J.D. Norrie, Lancet, 395, 1525 (2020); https://doi.org/10.1016/S0140-6736(20)31023-0
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 0 Download : 0